Literature DB >> 1856414

Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure.

P F Binkley1, E Nunziata, G J Haas, S D Nelson, R J Cody.   

Abstract

Although enhanced sympathetic tone is a well recognized component of the autonomic profile characteristic of congestive heart failure, the contribution of parasympathetic withdrawal to this autonomic imbalance is less well described. The technique of spectral analysis of heart rate variability provides a dynamic map of sympathetic and parasympathetic tone and was thus used to define the nature of sympathetic-parasympathetic interactions in humans with idiopathic dilated cardiomyopathy and in a paced canine model of congestive heart failure. Humans with cardiomyopathy were found to have an augmentation of the sympathetically mediated low frequency area of the power density spectrum. Parasympathetic withdrawal was demonstrated by significant reductions in the parasympathetically mediated high frequency area (p less than 0.05) and the ratio of high to low frequency areas (p less than 0.01). Administration of atropine to normal subjects resulted in a significant reduction in the high frequency area (p less than 0.05) and the high/low frequency area ratio, both of which decreased within the range noted in patients with congestive heart failure. Administration of isoproterenol in normal subjects led to an augmentation of the low frequency area but to only a small decrease in the high/low frequency area ratio. Induction of congestive heart failure in a paced canine model resulted in alterations in the autonomic profile that resembled those seen in humans with ventricular failure. The prominent high frequency region of the spectrum at baseline, indicating a predominance of parasympathetic tone, was absent after the evolution of congestive heart failure, and there was a marked augmentation of the low frequency region of the spectrum.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856414     DOI: 10.1016/0735-1097(91)90602-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  65 in total

1.  Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status.

Authors:  J J Atherton; D J Blackman; T D Moore; A W Bachmann; T J Tunny; H L Thomson; R D Gordon; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

Review 2.  Evidence for impaired vagus nerve activity in heart failure.

Authors:  Steve Bibevski; Mark E Dunlap
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

3.  The role of the neurohormonal system in heart failure.

Authors:  M Komajda; F Pousset; R Isnard; P Lechat
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

4.  Heart rate variability during and after peripheral blood stem cell leukapheresis in autologous transplant patients and allogeneic transplant donors.

Authors:  Takahiko Nakane; Hirohisa Nakamae; Hideo Koh; Mika Nakamae; Ran Aimoto; Yoshiki Terada; Ki-Ryang Koh; Takahisa Yamane; Masayuki Hino
Journal:  Int J Hematol       Date:  2010-03-12       Impact factor: 2.490

5.  Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions.

Authors:  Ashbeel Roy; Mouhamed Dakroub; Geisa C S V Tezini; Yin Liu; Silvia Guatimosim; Qingping Feng; Helio C Salgado; Vania F Prado; Marco A M Prado; Robert Gros
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

6.  Sympathetic nervous system, systolic heart failure, and central sleep apnea: Are we about to find the missing link?

Authors:  Olivier Lairez; Damien Legallois; Denis Agostini
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

7.  Pupillary autonomic dysfunction in patients with ANCA-associated vasculitis.

Authors:  Philipp Moog; O Eren; S Kossegg; K Valda; A Straube; M Grünke; H Schulze-Koops; M Witt
Journal:  Clin Auton Res       Date:  2017-09-01       Impact factor: 4.435

8.  Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure.

Authors:  A S Androne; K Hryniewicz; R Goldsmith; A Arwady; S D Katz
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Post-exercise heart rate recovery independently predicts mortality risk in patients with chronic heart failure.

Authors:  Yi-Da Tang; Thomas A Dewland; Detlef Wencker; Stuart D Katz
Journal:  J Card Fail       Date:  2009-08-05       Impact factor: 5.712

10.  Differential autonomic mechanisms underlying early morning and daytime transient myocardial ischaemia in patients with stable coronary artery disease.

Authors:  A J van Boven; J Brouwer; H J Crijns; J Haaksma; K I Lie
Journal:  Br Heart J       Date:  1995-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.